Linda Dudzinski-Johnson PharmD, MBA, MSPharm

Linda Dudzinski-Johnson has extensive work experience in the pharmaceutical industry. Linda currently holds the role of Senior Medical Science Liaison, Rare Disease, Neurology/Sleep at Avadel Pharmaceuticals plc, starting in November 2022. Prior to this, they worked at Regeneron as Associate Director, Field Medical Affairs, Oncology and Associate Director, Field Medical Affairs, Infectious Disease, starting in May 2021 and August 2021 respectively. Before joining Regeneron, Linda worked at AbbVie as a Medical Science Liaison-Migraine, starting in June 2019. Linda also gained significant experience at Eli Lilly and Company, where they held multiple roles including Outcomes Liaison in Oncology and Neuroscience/Men's Health, Account Based Manager in Neuroscience, and Community Mental Health Sr. Sales Representative in Neuroscience. With over 20 years of experience in the industry, Linda has received awards and recognition for their work, including the Global Health Outcomes Bi-Yearly Leadership Award in 2012 and the U.S. Medical Division Teamwork Award in 2011.

Linda Dudzinski-Johnson holds a Doctor of Pharmacy (PharmD) degree from the University of Michigan. Additionally, they completed a Master of Science in Pharmacy (MSPharm) degree specializing in Pharmaceutical Outcomes & Policy, with a focus on Applied Pharmacoeconomics, at the University of Florida from 2016 to 2018. Linda also pursued a Master of Business Administration (MBA) degree in Business Administration and Management from Stetson University between 2015 and 2018. Furthermore, they obtained a Certificate in Applied Pharmacoeconomics from the University of Florida from 2013 to 2016.